Health product recall

Sanis Health Duloxetine 60 mg Capsule; Exceeds acceptable interim intake limit for N-nitroso-duloxetine (NDLX)

Last updated

Summary

Product
Sanis Health Duloxetine 60 mg Capsule
Issue
Health products - Product quality
What to do

Consult your health care professional if you have any health concerns. 

Affected products

Brand

Product Name

Market Authorization

Dosage Form

Strength

Lot numbers

Sanis Health

Duloxetine 60 mg Capsule

DIN 02490897

Capsule (Delayed Release)

Duloxetine Hydrochloride 60 mg

644182

Issue

The affected lot exceed the interim acceptable intake limit for N-nitroso-duloxetine (NDLX).

What you should do

  1. Verify if your product is affected.
  2. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
  3. Contact the recalling firm if you have any questions about the recall.
  4. Report any health product related side effects to Health Canada.
  5. Report any other health product safety complaints to Health Canada.

Additional information

Background

Depth of recall: Retailers

Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies

Sanis Health Inc.

243 Consumers Road, 

Toronto Ontario M2J 4W8

Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type II
Identification number
RA-75527

Get notified

Receive notifications for new and updated recalls and alerts by category.

Subscribe